A complete backbone spectral assignment of lipid-free human apolipoprotein E (apoE)

Cornilescu G, Delaglio F, Bax A (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13(3):289–302. doi:10.1023/A:1008392405740 Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923. doi:10.1126/science.8346443 Dong LM, Weisgraber KH (1996) Human apolipoprotein E4 domain interaction Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271:19053–19057. doi:10.1074/jbc.271.32.19053 Eghbalnia HR, Wang L, Bahrami A, Assadi A, Markley JL (2005) Protein energetic conformational analysis from NMR chemical shifts (PECAN) and its use in determining secondary structural elements. J Biomol NMR 32:71–81. doi:10.1007/s10858-005-5705-1 Fan D, Li Q, Korando L, Jerome WG, Wang J (2004) A monomeric human apolipoprotein E carboxyl-terminal domain. Biochemistry 43:5055–5064. doi:10.1021/bi035958w Huang Y, von Eckardstein A, Wu S, Maeda N, Assmann G (1994) A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci USA 91:1834–1838. doi:10.1073/pnas.91.5.1834 Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507–537. doi:10.1146/annurev.genom.1.1.507 Mahley RW, Huang Y (1999) Apolipoprotein E: from atherosclerosis to Alzheimer’s disease and beyond. Curr Opin Lipidol 10:207–217. doi:10.1097/00041433-199906000-00003 Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem 281:1073–1079. doi:10.1074/jbc.M510851200 Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G (1981) Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 68:1075–1085. doi:10.1172/JCI110330 Sivashanmugam A, Victoria Meiners, Chunxian Cui, Yunhuang Yang, Jianjun Wang, Qianqian Li (2008) Practical protocols for production of very high-yield of recombinant proteins in Eschericia coli. Submitted to Protein Sci Weisgraber KH (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45:249–302. doi:10.1016/S0065-3233(08)60642-7 Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252:1817–1822. doi:10.1126/science.2063194 Wishart DS, Sykes BD, Richards FM (1992) The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31:1647–1651. doi:10.1021/bi00121a010 Xu C, Sivashanmugam A, Hoyt D, Wang J (2005) A complete backbone assignment of the human apolipoprotein E LDL-receptor-binding domain. J Biomol NMR 32:177. doi:10.1007/s10858-005-6729-2 Zhang Y, Vasudevan S, Sojitrawala R, Zhao W, Cui C, Xu C et al (2007) A monomeric, biologically active, full-length human apolipoprotein E. Biochemistry 46:10722–10732. doi:10.1021/bi700672v Zhao W, Zhang Y, Cui C, Li Q, Wang J (2008) An efficient on-column expressed protein ligation strategy: application to segmental triple labeling of human apolipoprotein E3. Protein Sci 17:736–747. doi:10.1110/ps.073383708